RT @HeoroCom: #Model: testing for #LynchSyndrome in early #colorectalCancer likely #costeffective, UK: ICER from £5,491/QALY https://t.co/F…
RT @HeoroCom: #Model: testing for #LynchSyndrome in early #colorectalCancer likely #costeffective, UK: ICER from £5,491/QALY https://t.co/F…
#Model: testing for #LynchSyndrome in early #colorectalCancer likely #costeffective, UK: ICER from £5,491/QALY https://t.co/Fyn1U4NMi9
Strategies to identify Lynch syndrome in young colorectal cancer patients. @Doctor_IMF http://t.co/lhEcdg7CeN
Strategies to identify Lynch syndrome in young colorectal cancer patients. @Doctor_IMF http://t.co/lhEcdg7CeN
Strategies to identify Lynch syndrome in young colorectal cancer patients. @Doctor_IMF http://t.co/lhEcdg7CeN
Strategies to identify Lynch syndrome in young colorectal cancer patients. @Doctor_IMF http://t.co/lhEcdg7CeN
Strategies to identify Lynch syndrome in young colorectal cancer patients. @Doctor_IMF http://t.co/lhEcdg7CeN
The cost-utility of strategies to identify Lynch syndrome in early-onset colorectal cancer patients. http://t.co/dpEJ5piGuS
◈ A model-based assessment of the cost–utility of strategies to identify Lynch syndrome in early-onset col... http://t.co/al6i84vLG4 ◈
A model-based assessment of the cost–utility of strategies to identify Lynch syndrome in early-onset c... http://t.co/gUyyEK9Gf8 #cancer
Model-based assessment on cost-utility of strategies to identify Lynch in early-onset CRC. - PubMed - NCBI http://t.co/SP949cMpXE
A model-based assessment of the cost–utility of strategies to identify Lynch syndrome in early-onset c... http://t.co/gUyyEK9Gf8 #cancer
◈ A model-based assessment of the cost–utility of strategies to identify Lynch syndrome in early-onset col... http://t.co/al6i84vLG4 ◈